Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Polycystic Ovary Syndrome peptide trials
4 selected ClinicalTrials.gov records carrying the official condition label Polycystic Ovary Syndrome. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
4 selected records.
3 profiles.
2005–2025 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 76 selected PubMed records and 40 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Polycystic Ovary Syndrome unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00757185
PeptideScanner retained ClinicalTrials.gov record NCT00757185 at 2026-11-15T22:03:26.540Z. Its registry update date was 2016-07-04, and PeptideScanner's reviewed identity mapping was ganirelix.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- July 4, 2016
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01402336
PeptideScanner retained ClinicalTrials.gov record NCT01402336 at 2026-11-15T22:02:39.332Z. Its registry update date was 2017-10-10, and PeptideScanner's reviewed identity mapping was cetrorelix.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 10, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05751252
PeptideScanner retained ClinicalTrials.gov record NCT05751252 at 2026-11-15T22:03:26.540Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was ganirelix.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 27, 2025
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Ganirelix · 2025-04-27
ClinicalTrials.gov record NCT05751252
Completed at the retained observation.
Open attributed record →Cetrorelix · 2017-10-10
ClinicalTrials.gov record NCT01402336
Completed at the retained observation.
Open attributed record →Ganirelix · 2016-07-04
ClinicalTrials.gov record NCT00757185
Completed at the retained observation.
Open attributed record →Leuprolide · 2005-06-24
ClinicalTrials.gov record NCT00004311
Completed at the retained observation.
Open attributed record →